Graft Versus Host Disease

Graft versus host disease (GVHD) is a complication that can develop after a person has had a bone marrow or stem cell transplant. In the disease, the host body comes under attack from the donated cells.
What is Graft Versus Host Disease (GVHD)?

Graft versus host disease (GVHD) is a complication that can develop after a person has had a bone marrow or stem cell transplant. In the disease, the host body comes under attack from the donated cells.

Read More

Overview

Feature Articles

Latest Graft Versus Host Disease News and Research

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Umbilical cord blood safely and effectively treats children with rare genetic disorders

Umbilical cord blood safely and effectively treats children with rare genetic disorders

Ruxolitinib shows promise in severe COVID-19

Ruxolitinib shows promise in severe COVID-19

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

Temperature fluctuations could give early indications of graft-versus-host disease

Temperature fluctuations could give early indications of graft-versus-host disease

Stem cell transplant following treatment with PD-1 inhibitor is safe, effective for patients with Hodgkin lymphoma

Stem cell transplant following treatment with PD-1 inhibitor is safe, effective for patients with Hodgkin lymphoma

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

Adding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

Adding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

A major step toward preventing GvHD in patients receiving bone marrow transplants

A major step toward preventing GvHD in patients receiving bone marrow transplants

New stem cell technology gives new hope for high-risk leukemia patients

New stem cell technology gives new hope for high-risk leukemia patients

New stem cell transplant lowers complications for patients with acute blood cancers

New stem cell transplant lowers complications for patients with acute blood cancers

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

Single-cell encapsulation technology can protect transplanted MSCs from immune attack

Single-cell encapsulation technology can protect transplanted MSCs from immune attack

Thioredoxin antioxidant could soon be used to improve cancer treatment

Thioredoxin antioxidant could soon be used to improve cancer treatment

Virus employs powerful strategy to inhibit natural killer cell function

Virus employs powerful strategy to inhibit natural killer cell function

Benefit of allogeneic stem cell transplantation in non-Hodgkin lymphoma remains unclear

Benefit of allogeneic stem cell transplantation in non-Hodgkin lymphoma remains unclear

Early clinical trial of new treatment for severe dry eye disease shows promising results

Early clinical trial of new treatment for severe dry eye disease shows promising results

Study compares use of breast milk to formula in children who underwent bone marrow transplant

Study compares use of breast milk to formula in children who underwent bone marrow transplant

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

FDA approves new oral drug to treat relapsing forms of multiple sclerosis